Primary experience of transcatheter therapy of combined congenital heart disease

Tao ZHOU,Xiang-qian SHEN,Sheng-hua ZHOU,Shu-shan QI,Zheng-fei FANG,Xin-qun HU,Xiao-ling LU
DOI: https://doi.org/10.3969/j.issn.1672-2019.2007.08.015
2007-01-01
Abstract:[Objective] To evaluate the possibility, methods and efficiency of intervention catheterization for combined congenital heart disease. [Methods] 13 patients (7 male) underwent transtheter intervention for combined congenital heart disease. Their mean age was (25.2±20.3) years. Types of the combination were as follows:ASD and VSD, 2 cases;ASD and PS, 2 cases;ASD and MS, 1 case;ASD and coronary artery stenosis, which needed interventional treatment, 1 case;VSD and PDA, 3 cases;ASD and anomalous inferior vein cava drainage, 1 case;PDA and B-preexcitation syndrome, 1 case;PDA and dextrocardia, anomalous inferior vein cava drainage, 1 case. Tactics of transtheter intervention was:for ASD and other deformities, ASD was occluded after the other deformities were treated;VSD and PDA, occlusion PDA first, VSD later;PDA and B-preexcitation syndrome, RFCA first, occlusion PDA later. The patients were followed up for 1 month, 3 months, 6 months and 1 year. [Results] Transtheter intervention for combined congenital heart disease was successful in all patients. Immediately after the procedure, this was no obvious residual shunt in occluded ASDs, VSDs or PDAs. The systolic pressure gradients across pulmonary valve decreased from (78.5±28.9) mmHg to (21.4±6.8) mmHg. During (11.0±8.8) months follow-up, no residual shunt and complications were observed. [Conclusion] Transcatheter intervention for combined congenital heart disease is feasible and effective as long as indication and tactics of procedures were appropriate.
What problem does this paper attempt to address?